Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Kane John M.; Peters-Strickland Timothy; Baker Ross A.; Hertel Peter; Eramo Anna; Jin Na; Perry Pamela P.; Gara Michelle; McQuade Robert D.; Carson William H.; Sanchez Raymond

首页> 外文期刊>The journal of clinical psychiatry >Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

【24h】

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

机译：阿立哌唑每月一次急性治疗精神分裂症：一项为期12周，随机，双盲，安慰剂对照研究的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To evaluate aripiprazole once-monthly (AOM), a long-acting injectable suspension of aripiprazole, as acute treatment in patients with schizophrenia (DSM-IV-TR).

机译：目的：评估阿立哌唑的长效注射剂阿立哌唑每月一次（AOM）作为精神分裂症患者的急性治疗（DSM-IV-TR）。

著录项

来源
《The journal of clinical psychiatry 》 |2014年第11期| 共7页
作者
Kane John M.; Peters-Strickland Timothy; Baker Ross A.; Hertel Peter; Eramo Anna; Jin Na; Perry Pamela P.; Gara Michelle; McQuade Robert D.; Carson William H.; Sanchez Raymond;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study [J] . Kane John M., Peters-Strickland Timothy, Baker Ross A., The journal of clinical psychiatry . 2014 ,第11期

机译：阿立哌唑每月一次急性治疗精神分裂症：一项为期12周，随机，双盲，安慰剂对照研究的结果
2. Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study [J] . Nasser Azmi F., Henderson David C., Fava Maurizio, Journal of clinical psychopharmacology . 2016 ,第2期

机译：RBP-7000每月一次利培酮治疗急性精神分裂症的功效，安全性和耐受性8周，随机，双盲，安慰剂对照的多中心3期研究
3. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20mg/day for the treatment of patients with acute exacerbations of schizophrenia. [J] . McEvoy JP, Daniel DG, Carson-WH Jr, Journal of psychiatric research . 2007 ,第11期

机译：阿立哌唑10、15或20mg /天治疗精神分裂症急性加重患者的疗效和安全性的随机，双盲，安慰剂对照研究。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy tolerability and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed treatment comparison of double-blind randomized clinical trials [O] . Istvan M. Majer, Fiona Gaughran, Christophe Sapin, 2015

机译：每月一次阿立哌唑与其他长效抗精神病药注射剂在精神分裂症维持治疗中的疗效耐受性和安全性：双盲随机临床试验的混合治疗比较
7. PMH50 Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia [O] . Fleischhacker W.W., Perry P., Sanchez R., 2013

机译：在两项针对精神分裂症的双盲，安慰剂和主动对照研究（Aspire US 246和Aspire EU 247）中，阿立哌唑每月一次PMH50功能性结果

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

摘要

著录项

相似文献

相关主题

期刊订阅